Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications

Pharmacology & Therapeutics
Ya-Xiong Tao

Abstract

Since the discovery of the first rhodopsin mutation that causes retinitis pigmentosa in 1990, significant progresses have been made in elucidating the pathophysiology of diseases caused by inactivating mutations of G protein-coupled receptors (GPCRs). This review aims to compile the compelling evidence accumulated during the past 15 years demonstrating the etiologies of more than a dozen diseases caused by inactivating GPCR mutations. A generalized classification scheme, based on the life cycle of GPCRs, is proposed. Insights gained through detailed studies of these naturally occurring mutations into the structure-function relationship of these receptors are reviewed. Therapeutic approaches directed against the different classes of mutants are being developed. Since intracellular retention emerges as the most common defect, recent progresses aimed at correcting this defect through membrane permeable pharmacological chaperones are highlighted.

References

Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C H SungJ Nathans
Oct 5, 1990·Science·R R FrankeK P Hofmann
Mar 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·R J LefkowitzI Pastan
Jan 19, 1995·The New England Journal of Medicine·T SunthornthepvarakulS Refetoff
Jul 1, 1995·Baillière's Clinical Endocrinology and Metabolism·A Shenker
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·N J ColleyC S Zuker
Sep 1, 1993·The Journal of Clinical Investigation·A M SpiegelA Shenker
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·L Roselli-RehfussR D Cone
Jan 12, 1996·The Journal of Biological Chemistry·S SatoR R Kopito
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·C E GariepyM Yanagisawa
Nov 1, 1995·Human Molecular Genetics·I CeccheriniD T Cass
Dec 1, 1995·Human Molecular Genetics·T AttiéS Lyonnet
Dec 1, 1995·The Journal of Clinical Investigation·S H PearceM P Whyte

❮ Previous
Next ❯

Citations

Jul 24, 2010·Cellular and Molecular Life Sciences : CMLS·Ann-Karin HaasGerd Krause
May 7, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yana BrombergBurkhard Rost
Oct 13, 2006·Annual Review of Pharmacology and Toxicology·Martine J SmitRob Leurs
Jun 14, 2012·Journal of Molecular Endocrinology·Run YuJános T Kodra
Sep 28, 2012·Journal of Molecular Endocrinology·Xiu-Lei MoYa-Xiong Tao
Nov 17, 2012·Journal of Clinical Research in Pediatric Endocrinology·Alessandra CassioLilia Baldazzi
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Noriko MakitaTaroh Iiri
May 2, 2014·Journal of Molecular Endocrinology·Xiao-Hua WangZhen-Chuan Fan
Jun 18, 2011·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Run YuCuiqi Zhou
Jul 9, 2011·Molecular and Cellular Endocrinology·Sekoni D Noel, Ursula B Kaiser
Mar 21, 2009·Journal of Cellular and Molecular Medicine·Zhen-Chuan Fan, Ya-Xiong Tao
Aug 16, 2011·Biochimica Et Biophysica Acta·Derek P NgCharles M Deber
Apr 2, 2016·The International Journal of Biochemistry & Cell Biology·Feroz Ahmed ShaikPrashen Chelikani
Jul 30, 2015·Journal of Molecular Endocrinology·Zhao YangYa-Xiong Tao
Jul 7, 2011·Biochimica Et Biophysica Acta·Zhi-Qiang Wang, Ya-Xiong Tao
Jul 24, 2015·Genome Biology·Diana Le DucTorsten Schöneberg
Aug 1, 2015·Genes & Diseases·Henriette Stoy, Vsevolod V Gurevich
Dec 21, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ulla E Petäjä-Repo, Jarkko J Lackman
Oct 31, 2006·Biochimica Et Biophysica Acta·Graeme Milligan
Nov 4, 2006·Biochimica Et Biophysica Acta·Paul A InselMartin C Michel
May 7, 2016·Journal of Molecular Endocrinology·Gunnar KleinauHeike Biebermann
Oct 30, 2016·The Journal of Pharmacology and Experimental Therapeutics·Bina JulianAlan S Kopin
Feb 15, 2018·Physiological Reviews·Ya-Xiong Tao, P Michael Conn
Oct 11, 2007·Human Mutation·Jeroen KaziusAd P Ijzerman
Apr 13, 2007·Acta Physiologica·B B FredholmG Milligan
Feb 5, 2011·Molecular Endocrinology·Annika KreuchwigGerd Krause
Apr 24, 2013·Molecular Endocrinology·Lucie ChevrierNicolas de Roux
Jan 1, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sekoni D NoelUrsula B Kaiser
Feb 7, 2009·Molecular Endocrinology·Jean-Pierre VilardagaCarsten Hoffmann
Jan 25, 2020·Nature Reviews. Endocrinology·Victoria D LeitchGraham R Williams
Mar 26, 2014·Endocrine Reviews·Ya-Xiong Tao, P Michael Conn
Dec 20, 2019·ELife·Qingtong ZhouSuwen Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.